Monday January 7, 2008, 1:30 p.m. - 3:00 p.m.
Click here to launch "Biotech Licensing" Slideshow
Jennifer Tegfeldt - Biography:
Jennifer Tegfeldt focuses her practice in the area of transactional intellectual property and business development as Director, Business Initiatives and Strategy in the Corporate Development group of Genzyme Corporation, Cambridge, Massachusetts. She is deployed to meet the needs of various business areas of the company including Corporate Science, Renal, Endocrine, Immune Mediated Diseases, Transplant, Lysosomal Storage Diseases and Rare Genetic Diseases, and her frequent focus is on technology evaluations, early stage science collaborations, licensing, alliance management, and acquisitions. She received a J.D. from Franklin Pierce Law Center in 1985, and was the first alumnus to be appointed as a law clerk by a Circuit Judge of the Court of Appeals for the Federal Circuit. Jennifer served as law clerk to the Honorable Pauline Newman from 1985-1987.
Before joining Genzyme in 1994, Jennifer practiced law with Fitzpatrick, Cella, Harper and Scinto in the firm's Washington D.C. office. She is registered to practice before the U.S. Patent and Trademark Office, and is admitted to practice in Washington, D.C. and the Commonwealth of Massachusetts, and before the Court of Appeals for the Federal Circuit. She received her Bachelor of Science in Biology from the University of California, Davis. Jennifer has been very active in such organizations as the Federal Circuit Bar Association, AIPLA, American Bar Association, including gaining Delegate status in the ABA's House of Delegates for the Federal Circuit Bar Association, the American Inns of Court, Giles S. Rich Inn, the Licensing Executives Society, and Pierce Law's Advisory Council on Intellectual Property. Jennifer is a frequent speaker and author on intellectual property, licensing and collaboration issues for legal and business conferences, and is a featured lecturer for Pierce Law's Annual Advanced Licensing Institute.